Acusensus（ACE）株式概要アキュセンサス・リミテッドは、オーストラリア、米国、英国において、脇見運転、シートベルト着用、スピード違反、踏切遵守、監視車両の検出と起訴可能な証拠の提供に焦点を当てた技術を開発している。 詳細ACE ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長1/6過去の実績0/6財務の健全性6/6配当金0/6報酬収益は年間15.06%増加すると予測されています リスク分析過去1年間で株主の希薄化が進んだ 現在は利益が出ておらず、今後3年間で利益が出る見込みはない すべてのリスクチェックを見るACE Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueAU$Current PriceAU$1.2372.5% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-23m143m2016201920222025202620282031Revenue AU$142.9mEarnings AU$16.7mAdvancedSet Fair ValueView all narrativesAcusensus Limited 競合他社ReadyTech HoldingsSymbol: ASX:RDYMarket cap: AU$179.2mDUG TechnologySymbol: ASX:DUGMarket cap: AU$294.0mPraemiumSymbol: ASX:PPSMarket cap: AU$338.8mEnergy OneSymbol: ASX:EOLMarket cap: AU$393.7m価格と性能株価の高値、安値、推移の概要Acusensus過去の株価現在の株価AU$1.2352週高値AU$2.1152週安値AU$0.81ベータ0.161ヶ月の変化-10.58%3ヶ月変化-22.96%1年変化28.27%3年間の変化89.04%5年間の変化n/aIPOからの変化53.13%最新ニュースお知らせ • Feb 11Acusensus Limited to Report First Half, 2026 Results on Feb 26, 2026Acusensus Limited announced that they will report first half, 2026 results on Feb 26, 2026New Risk • Dec 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.5m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).お知らせ • Dec 16Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,892,287 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,107,713 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Transaction Features: Subsequent Direct Listingお知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 19, 2025Acusensus Limited, Annual General Meeting, Nov 19, 2025. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, AustraliaReported Earnings • Aug 27Full year 2025 earnings released: AU$0.02 loss per share (vs AU$0.012 loss in FY 2024)Full year 2025 results: AU$0.02 loss per share (further deteriorated from AU$0.012 loss in FY 2024). Revenue: AU$59.4m (up 20% from FY 2024). Net loss: AU$2.62m (loss widened 72% from FY 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Australia.お知らせ • Aug 15Acusensus Limited to Report Fiscal Year 2025 Results on Aug 26, 2025Acusensus Limited announced that they will report fiscal year 2025 results on Aug 26, 2025最新情報をもっと見るRecent updatesお知らせ • Feb 11Acusensus Limited to Report First Half, 2026 Results on Feb 26, 2026Acusensus Limited announced that they will report first half, 2026 results on Feb 26, 2026New Risk • Dec 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.5m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).お知らせ • Dec 16Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,892,287 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,107,713 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Transaction Features: Subsequent Direct Listingお知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 19, 2025Acusensus Limited, Annual General Meeting, Nov 19, 2025. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, AustraliaReported Earnings • Aug 27Full year 2025 earnings released: AU$0.02 loss per share (vs AU$0.012 loss in FY 2024)Full year 2025 results: AU$0.02 loss per share (further deteriorated from AU$0.012 loss in FY 2024). Revenue: AU$59.4m (up 20% from FY 2024). Net loss: AU$2.62m (loss widened 72% from FY 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Australia.お知らせ • Aug 15Acusensus Limited to Report Fiscal Year 2025 Results on Aug 26, 2025Acusensus Limited announced that they will report fiscal year 2025 results on Aug 26, 2025お知らせ • Feb 02Acusensus Limited to Report First Half, 2025 Results on Feb 27, 2025Acusensus Limited announced that they will report first half, 2025 results on Feb 27, 2025New Risk • Jan 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$149.0m market cap, or US$91.6m).お知らせ • Dec 20Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405お知らせ • Dec 07Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,111,112 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405 Transaction Features: Subsequent Direct Listingお知らせ • Dec 04+ 1 more updateAcusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 21, 2024Acusensus Limited, Annual General Meeting, Nov 21, 2024. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, melbourne AustraliaNew Risk • Sep 02New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: AU$1.5m Forecast net loss in 3 years: AU$1.2m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$1.2m net loss in 3 years). Market cap is less than US$100m (AU$87.2m market cap, or US$59.0m).New Risk • Aug 27New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 37% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 37% per year for the foreseeable future. Minor Risks Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (AU$82.2m market cap, or US$55.7m).Recent Insider Transactions • Jun 14Independent Non-Executive Director recently bought AU$75k worth of stockOn the 11th of June, Susan Klose bought around 125k shares on-market at roughly AU$0.60 per share. This transaction increased Susan's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.New Risk • Feb 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (AU$96.1m market cap, or US$62.9m).お知らせ • Oct 10Acusensus Limited Appoints Michael Lawrence Giuffrida as DirectorAcusensus Limited announced the appointment of Michael Lawrence Giuffrida as an independent non-executive Director, effective from October 9, 2023. Mr. Giuffrida's appointment follow the resignation of thomas patterson from the board in june 2023. Mr. Giuffrida is an entrepreneur with over 25 year of experience, having co=founded and been the CEO pf a human resource technology company, Acendre Pty Ltd. in 1997. Under Mike's leadership, acendre subsequently established a presence in the US, including in the US federal government market, before leading a process to identify a mojority growth investment partener for Acendre and subsequent acquisition of a US based HR technology company. At the end of 2019, Mike led a successfull trasition to a US based CEO to head up Acendre's next phase of growth, which enabled Mike to return to australia full time with his family.Reported Earnings • Aug 26Full year 2023 earnings releasedFull year 2023 results: Revenue: AU$42.0m (up 47% from FY 2022). Net income: AU$55.0k (down 96% from FY 2022). Profit margin: 0.1% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia.New Risk • Aug 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (AU$92.1m market cap, or US$58.9m).お知らせ • Aug 24Acusensus Limited, Annual General Meeting, Nov 16, 2023Acusensus Limited, Annual General Meeting, Nov 16, 2023.Buying Opportunity • Jul 18Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be AU$4.00, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 70% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.Board Change • Jun 01Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Sue Klose was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Sue Klose was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 04Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Sue Klose was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Jan 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.株主還元ACEAU SoftwareAU 市場7D-1.2%-5.1%1.7%1Y28.3%-49.0%2.2%株主還元を見る業界別リターン: ACE過去 1 年間で-49 % の収益を上げたAustralian Software業界を上回りました。リターン対市場: ACE過去 1 年間で2.2 % の収益を上げたAustralian市場を上回りました。価格変動Is ACE's price volatile compared to industry and market?ACE volatilityACE Average Weekly Movement6.3%Software Industry Average Movement10.1%Market Average Movement10.1%10% most volatile stocks in AU Market17.2%10% least volatile stocks in AU Market4.0%安定した株価: ACE 、 Australian市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: ACEの 週次ボラティリティ ( 6% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト2018261Alex Janninkwww.acusensus.comアキュセンサス・リミテッド（Acusensus Limited）は、オーストラリア、米国、英国において、脇見運転、シートベルト着用、スピード違反、踏切遵守、対象車両の監視など、訴追可能な証拠の検出と提供に焦点を当てた技術を開発している。違法な携帯電話使用、シートベルト非装着、スピード違反の検知と訴追可能な証拠の取得に使用されるヘッドズ・アップ・ソリューション、ドライバーの電話使用、スピード違反、シートベルト非装着を警察官にリアルタイムで警告するヘッドズ・アップ・リアルタイム・ソリューション、先進国および発展途上国で使用されるハーモニー取締カメラシステム、道路作業員の安全空間のためのロード・ワーカー・セーフティを提供している。同社は2018年に法人化され、オーストラリアのメルボルンを拠点としている。もっと見るAcusensus Limited 基礎のまとめAcusensus の収益と売上を時価総額と比較するとどうか。ACE 基礎統計学時価総額AU$205.62m収益（TTM）-AU$22.93m売上高(TTM)AU$70.84m2.9xP/Sレシオ-9.0xPER（株価収益率ACE は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計ACE 損益計算書（TTM）収益AU$70.84m売上原価AU$41.48m売上総利益AU$29.36mその他の費用AU$52.29m収益-AU$22.93m直近の収益報告Dec 31, 2025次回決算日該当なし一株当たり利益（EPS）-0.14グロス・マージン41.44%純利益率-32.36%有利子負債／自己資本比率0%ACE の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/12 07:52終値2026/06/12 00:00収益2025/12/31年間収益2025/06/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Acusensus Limited 3 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Owen HumphriesCanaccord GenuityRoss BarrowsCanaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd.James FiliusMorgans Financial Limited
お知らせ • Feb 11Acusensus Limited to Report First Half, 2026 Results on Feb 26, 2026Acusensus Limited announced that they will report first half, 2026 results on Feb 26, 2026
New Risk • Dec 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.5m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).
お知らせ • Dec 16Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,892,287 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,107,713 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Transaction Features: Subsequent Direct Listing
お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 19, 2025Acusensus Limited, Annual General Meeting, Nov 19, 2025. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, Australia
Reported Earnings • Aug 27Full year 2025 earnings released: AU$0.02 loss per share (vs AU$0.012 loss in FY 2024)Full year 2025 results: AU$0.02 loss per share (further deteriorated from AU$0.012 loss in FY 2024). Revenue: AU$59.4m (up 20% from FY 2024). Net loss: AU$2.62m (loss widened 72% from FY 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Australia.
お知らせ • Aug 15Acusensus Limited to Report Fiscal Year 2025 Results on Aug 26, 2025Acusensus Limited announced that they will report fiscal year 2025 results on Aug 26, 2025
お知らせ • Feb 11Acusensus Limited to Report First Half, 2026 Results on Feb 26, 2026Acusensus Limited announced that they will report first half, 2026 results on Feb 26, 2026
New Risk • Dec 30New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 16% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 8.5% per year for the foreseeable future. Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$3.5m net loss in 3 years). Shareholders have been diluted in the past year (16% increase in shares outstanding).
お知らせ • Dec 16Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 30 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 6,892,287 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 13,107,713 Price\Range: AUD 1.5 Discount Per Security: AUD 0.06 Transaction Features: Subsequent Direct Listing
お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 19, 2025Acusensus Limited, Annual General Meeting, Nov 19, 2025. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, Australia
Reported Earnings • Aug 27Full year 2025 earnings released: AU$0.02 loss per share (vs AU$0.012 loss in FY 2024)Full year 2025 results: AU$0.02 loss per share (further deteriorated from AU$0.012 loss in FY 2024). Revenue: AU$59.4m (up 20% from FY 2024). Net loss: AU$2.62m (loss widened 72% from FY 2024). Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Software industry in Australia.
お知らせ • Aug 15Acusensus Limited to Report Fiscal Year 2025 Results on Aug 26, 2025Acusensus Limited announced that they will report fiscal year 2025 results on Aug 26, 2025
お知らせ • Feb 02Acusensus Limited to Report First Half, 2025 Results on Feb 27, 2025Acusensus Limited announced that they will report first half, 2025 results on Feb 27, 2025
New Risk • Jan 11New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 11% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Shareholders have been diluted in the past year (11% increase in shares outstanding). Significant insider selling over the past 3 months (AU$1.5m sold). Market cap is less than US$100m (AU$149.0m market cap, or US$91.6m).
お知らせ • Dec 20Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405
お知らせ • Dec 07Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million.Acusensus Limited has completed a Follow-on Equity Offering in the amount of AUD 10.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 11,111,112 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405 Transaction Features: Subsequent Direct Listing
お知らせ • Dec 04+ 1 more updateAcusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million.Acusensus Limited has filed a Follow-on Equity Offering in the amount of AUD 2.000001 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 2,222,223 Price\Range: AUD 0.9 Discount Per Security: AUD 0.0405
お知らせ • Oct 17Acusensus Limited, Annual General Meeting, Nov 21, 2024Acusensus Limited, Annual General Meeting, Nov 21, 2024. Location: dexus place, north tower, level 6, 80 collins street, melbourne vic 3000, melbourne Australia
New Risk • Sep 02New minor risk - ProfitabilityThe company is currently unprofitable and not forecast to become profitable over the next 3 years. Trailing 12-month net loss: AU$1.5m Forecast net loss in 3 years: AU$1.2m This is considered a minor risk. Companies that are not profitable are more likely to be burning through cash and less likely to be well established. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. Without profits, the company is under pressure to grow significantly while potentially having to reduce costs and possibly needing to take on debt or raise capital to remain afloat. Currently, the following risks have been identified for the company: Minor Risks Currently unprofitable and not forecast to become profitable over next 3 years (AU$1.2m net loss in 3 years). Market cap is less than US$100m (AU$87.2m market cap, or US$59.0m).
New Risk • Aug 27New major risk - Revenue and earnings growthEarnings are forecast to decline by an average of 37% per year for the foreseeable future. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are expected to decline, then in most cases the share price will decline over time as well. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings are forecast to decline by an average of 37% per year for the foreseeable future. Minor Risks Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (AU$82.2m market cap, or US$55.7m).
Recent Insider Transactions • Jun 14Independent Non-Executive Director recently bought AU$75k worth of stockOn the 11th of June, Susan Klose bought around 125k shares on-market at roughly AU$0.60 per share. This transaction increased Susan's direct individual holding by 1x at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
New Risk • Feb 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 23% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (13% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (0.2% net profit margin). Market cap is less than US$100m (AU$96.1m market cap, or US$62.9m).
お知らせ • Oct 10Acusensus Limited Appoints Michael Lawrence Giuffrida as DirectorAcusensus Limited announced the appointment of Michael Lawrence Giuffrida as an independent non-executive Director, effective from October 9, 2023. Mr. Giuffrida's appointment follow the resignation of thomas patterson from the board in june 2023. Mr. Giuffrida is an entrepreneur with over 25 year of experience, having co=founded and been the CEO pf a human resource technology company, Acendre Pty Ltd. in 1997. Under Mike's leadership, acendre subsequently established a presence in the US, including in the US federal government market, before leading a process to identify a mojority growth investment partener for Acendre and subsequent acquisition of a US based HR technology company. At the end of 2019, Mike led a successfull trasition to a US based CEO to head up Acendre's next phase of growth, which enabled Mike to return to australia full time with his family.
Reported Earnings • Aug 26Full year 2023 earnings releasedFull year 2023 results: Revenue: AU$42.0m (up 47% from FY 2022). Net income: AU$55.0k (down 96% from FY 2022). Profit margin: 0.1% (down from 5.0% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Software industry in Australia.
New Risk • Aug 25New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Shares are highly illiquid. Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Market cap is less than US$100m (AU$92.1m market cap, or US$58.9m).
お知らせ • Aug 24Acusensus Limited, Annual General Meeting, Nov 16, 2023Acusensus Limited, Annual General Meeting, Nov 16, 2023.
Buying Opportunity • Jul 18Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be AU$4.00, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 70% over the last 3 years. Meanwhile, the company has become profitable. Revenue is forecast to grow by 37% in 2 years. Earnings is forecast to grow by 19% in the next 2 years.
Board Change • Jun 01Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Sue Klose was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Sue Klose was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 04Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Sue Klose was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Jan 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. No highly experienced directors. No independent directors (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
